Health & Nutrition
FNArena Windows (Sectors)
Introduction to FNArena Windows
FNArena Windows offers subscribers the option to investigate ASX-listed stocks against their peers. FNArena developed its own sector methodology which in our view overcomes many flaws and disadvantages connected with GICS sectors. Our system starts with three broad sector labels: COMMODITIES, FINANCIAL SERVICES and INDUSTRIALS. From here onwards subscribers can explore further through gradually narrowing branches. This is not investment advice, but simply another window on the Australian Stock Exchange to provide better insight and to assist FNArena subscribers while conducting their own market analysis.
| ASX CODE | COMPANY NAME | LAST PRICE | 52WK HIGH | 52WK LOW | P/E | CONSENSUS TARGET |
|---|---|---|---|---|---|---|
| CLV | $0.53 | $0.60 | $0.34 |
$0.68 |
||
| EBO | EBOS GROUP LIMITED | $34.50 | $38.09 | $28.85 | 25.2 |
$36.317 |
| SIG | SIGMA HEALTHCARE LIMITED | $3.21 | $3.32 | $1.21 | 77.0 |
$2.956 |
Previous Stories
M&A Now On Sigma Healthcare’s Agenda
Mar 24 2021
Having completed its efficiency drive, Sigma Healthcare is looking to M&A to enable future growth
McPherson’s Expands Into Herbal Health
Nov 04 2020
McPherson’s has expanded into the herbal product segment by acquiring Global Therapeutics and can now build out that business across its pharmacy distribution channel.
Nine Ignored Companies Now Worth A Look
Sep 23 2020
Peter Switzer of the Switzer Report highlights nine stocks that aren’t his top picks, but that analysts believe offer solid upside ahead.
Next Week At A Glance – 14-18 Sep 2020
Sep 11 2020
A brief look at important company events and economic data releases next week
Sigma Farewells API, Heralds New Contract
Dec 17 2019
Sigma Healthcare has adjusted guidance to account for the renewed Chemist Warehouse contract, while Australian Pharmaceutical Industries finally takes its hat out of the merger ring.
Blackmores: Hopes Pinned On Restructuring
Nov 01 2019
Blackmores’ first half profit warning has sent analysts into a scramble to downgrade forecasts, but turnaround potential has been boosted by a shift in strategy.
Blackmores Peps Up Its Strategy For China
Apr 17 2019
Elevated inventory persisted over the March quarter amid falling sales for Blackmores, which has recognised the need to reposition its business to better cater for the Chinese market.
API/Sigma Merger Plan Rears, Again
Dec 17 2018
A merger of Australian Pharmaceutical Industries and Sigma Healthcare is logical but ACCC issues are uppermost in broker views.
Uncertainty Hinders Sigma Pharmaceuticals
Sep 11 2018
Uncertainty is likely to hinder Sigma Pharmaceuticals until a firm earnings base is established after the exit of its major customer.
Goodbye Chemist Warehouse, Hello Capital Return?
Jul 03 2018
Stockbrokers are still not keen on buying Sigma Healthcare shares, though a capital return might change their view.
Latest News
| 1 |
Geopolitical Hedging Drives Investor Confidence in CommBankJun 12 2025 - General |
| 2 |
testJun 12 2025 - General |
| 3 |
ASX Winners And Losers Of Today – 27-06-23Jun 27 2023 - General |
| 4 |
Metcash SurprisesJun 27 2023 - Uncategorized |
| 5 |
ASX200: Move To NeutralJun 27 2023 - Uncategorized |